Join us for our next challenge within the framework of the #thisway campaign, aimed at promoting physical and mental health within the rare bleeding disorder community!
Here’s what you need to know:
- Start date: Monday, March 25
- Duration: 4 weeks
- Track any form of physical activity, including walking, hiking, cycling, swimming… Even gardening and meditation! Every activity counts toward the workouts tracked.
- The top three participants with the most workouts tracked will win a prize.
Whether you’re naturally competitive or need that extra push, we’ve got you covered! With a range of incentives and recognition options, everyone has a reason to join in.
Engage with fellow participants, share experiences, and offer support, strengthening bonds within our community.
But that’s not all!
- 1st place winner gets a high-quality fitness tracker;
- 2nd place wins a high-quality gym bag;
- 3rd place receives awesome gym accessories (water bottle & workout towel).
How to participate:
- Download and create your account on the MapMyRun app: https://www.mapmyrun.com
- Sign up via: https://forms.gle/rfwLh2JeCK5aSgEY7
Get active, stay healthy, and manage your health conditions better. Moreover, by participating, you’re helping raise awareness about rare bleeding disorders and advocating for better healthcare and support.
Ready to take on the challenge? Let’s do this together!
Jim is aged 66 and has Haemophilia A with a high titer inhibitor which he developed at age 14.
Maria Elisa Mancuso (MD, PhD) is a Haematologist and works as a Senior Haematology Consultant at the Center for Thrombosis and Haemorrhagic Diseases of IRCCS Humanitas Research Hospital in Rozzano, Milan, Italy. She is Adjunct Clinical Professor at Humanitas University. She obtained a post-degree in Clinical and Experimental Haematology and a PhD in Clinical Methodology. She is involved in clinical research and has published several original articles in peer-reviewed journals a The Lancet, Blood, Journal of Thrombosis and Haemostasis, Haematologica, Thrombosis and Haemostasis, British Journal of Haematology and Haemophilia. She is reviewer for several peer-reviewed journals and member of the Editorial Board of JTH. She is a member of several scientific societies (ISTH, WFH, ASH, EAHAD, SISET, AICE) and was a medical member of the Inhibitor Working Group of the European Hemophilia Consortium. She is co-chair of the ADVANCE Study Group. She has acted also as co-chair of the Scientific and Standardization Subcommittee of ISTH on FVIII, FIX and rare bleeding disorders. She has been involved as principal and co-investigator in several clinical trials, and she takes care of both children and adults with hemophilia and other congenital bleeding disorders with a specific scientific interest in novel therapies, prophylaxis, inhibitors, and chronic hepatitis C.
As a patient with factor II deficiency, the diagnostic and treatment of rare bleeding disorders is a matter dear to my heart. My motivation to participate in the work of the ERIN committee is to improve both diagnostic and treatment for patients with rare bleeding disorders across Europe.
Economist and financial expert by profession, executive coach and trainer by passion and haemophilia advocate by every drop of my blood through my son (who has severe haemophilia A with inhibitors). Bringing a good decade of practical experience from the corporate insurance world, laser focus, growth mindset and resilience from my own experience, offering you anything I can just do, in hope that together we can make life more fulfilled for those impacted by bleeding disorders.
Amy Owen-Wyard is a Registered Mental Health Nurse. With experience working with children, young people, their families and adults with severe and enduring mental health conditions. Amy was also involved in a service improvement to provide a holistic care approach for those in general hospitals to support both their mental and physical health, whilst sharing her expertise and knowledge in mental health with the wider multidisciplinary team.
